NCT00112983 2013-05-30
Eculizumab in Treating Patients With Paroxysmal Nocturnal Hemoglobinuria
National Cancer Institute (NCI)
Phase 3 Completed
Clinical Trials
1 trialsPrecursor Cell Lymphoblastic Leukemia-Lymphoma × eculizumab × Other hematologic neoplasm × Clear all